Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Yuanji Pharmaceutical is a pharmaceutical company headquartered in Chengdu, China, specializing in the development and production of high-end generic medications and active pharmaceutical ingredients (APIs). The company focuses on several key therapeutic areas, including cardiovascular diseases, metabolic disorders, and anti-infective treatments. With a strong emphasis on R&D and manufacturing excellence, Yuanji Pharmaceutical operates facilities that meet international GMP standards. Their product portfolio features widely used treatments such as anticoagulants and SGLT2 inhibitors. The company serves both the domestic Chinese market and international partners through its integrated chemical synthesis and formulation capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Yuanji Pharmaceutical.